IL145483A0 - Bicyclic heteroaromatic compounds useful as lh agonists - Google Patents

Bicyclic heteroaromatic compounds useful as lh agonists

Info

Publication number
IL145483A0
IL145483A0 IL14548300A IL14548300A IL145483A0 IL 145483 A0 IL145483 A0 IL 145483A0 IL 14548300 A IL14548300 A IL 14548300A IL 14548300 A IL14548300 A IL 14548300A IL 145483 A0 IL145483 A0 IL 145483A0
Authority
IL
Israel
Prior art keywords
agonists
compounds useful
heteroaromatic compounds
bicyclic heteroaromatic
bicyclic
Prior art date
Application number
IL14548300A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL145483A0 publication Critical patent/IL145483A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL14548300A 1999-04-08 2000-04-03 Bicyclic heteroaromatic compounds useful as lh agonists IL145483A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99201152 1999-04-08
PCT/EP2000/002865 WO2000061586A1 (en) 1999-04-08 2000-04-03 Bicyclic heteroaromatic compounds useful as lh agonists

Publications (1)

Publication Number Publication Date
IL145483A0 true IL145483A0 (en) 2002-06-30

Family

ID=8240094

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14548300A IL145483A0 (en) 1999-04-08 2000-04-03 Bicyclic heteroaromatic compounds useful as lh agonists
IL145483A IL145483A (en) 1999-04-08 2001-09-16 Cyclic traumatic compounds are converted four times for use in pharmacotherapy, pharmaceutical preparations that include them and some new compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL145483A IL145483A (en) 1999-04-08 2001-09-16 Cyclic traumatic compounds are converted four times for use in pharmacotherapy, pharmaceutical preparations that include them and some new compounds

Country Status (30)

Country Link
US (2) US6569863B1 (cs)
EP (1) EP1171443B1 (cs)
JP (1) JP4854856B2 (cs)
KR (1) KR100691546B1 (cs)
CN (1) CN1177848C (cs)
AR (1) AR028474A1 (cs)
AT (1) ATE299507T1 (cs)
AU (1) AU772258B2 (cs)
BR (1) BRPI0009558B1 (cs)
CA (1) CA2368834C (cs)
CO (1) CO5160348A1 (cs)
CZ (1) CZ300832B6 (cs)
DE (1) DE60021262T2 (cs)
DK (1) DK1171443T3 (cs)
ES (1) ES2245304T3 (cs)
HK (1) HK1041266B (cs)
HU (1) HU229002B1 (cs)
ID (1) ID30502A (cs)
IL (2) IL145483A0 (cs)
MX (1) MXPA01010144A (cs)
NO (1) NO328826B1 (cs)
NZ (1) NZ514445A (cs)
PE (1) PE20010030A1 (cs)
PL (1) PL219316B1 (cs)
PT (1) PT1171443E (cs)
RU (1) RU2248979C2 (cs)
TR (1) TR200102839T2 (cs)
TW (1) TW564247B (cs)
WO (1) WO2000061586A1 (cs)
ZA (1) ZA200107917B (cs)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ524444A (en) * 2000-09-22 2004-03-26 Akzo Nobel Nv Bicyclic heteroaromatic compounds
GB0100622D0 (en) 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical compounds V111
DE10108481A1 (de) 2001-02-22 2002-10-24 Bayer Ag Pyridylpyrimidine
CA2457212C (en) * 2001-09-04 2011-02-15 Akzo Nobel Nv Glycine-substituted thieno [2,3-d]pyrimidines with combined lh and fsh agonistic activity
TWI228508B (en) * 2001-09-04 2005-03-01 Akzo Nobel Nv Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity
US6974870B2 (en) 2002-06-06 2005-12-13 Boehringer Ingelheim Phamaceuticals, Inc. Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
EP1513516B1 (en) 2002-06-06 2008-12-03 Boehringer Ingelheim Pharmaceuticals Inc. SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
WO2004092177A1 (en) 2003-04-09 2004-10-28 Biogen Idec Ma Inc. Triazolopyrazines and methods of making and using the same
US7285550B2 (en) 2003-04-09 2007-10-23 Biogen Idec Ma Inc. Triazolotriazines and pyrazolotriazines and methods of making and using the same
WO2004092173A2 (en) 2003-04-09 2004-10-28 Biogen Idec Ma Inc. A2a adenosine receptor antagonists
JPWO2005019225A1 (ja) * 2003-08-21 2007-11-01 杏林製薬株式会社 Ｎｋ１受容体拮抗作用を有する化合物の製造方法及びその製造中間体
US7550485B2 (en) * 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
WO2005039506A2 (en) * 2003-10-24 2005-05-06 Exelixis, Inc. P70s6 kinase modulators and method of use
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
EP1781289A1 (en) * 2004-07-22 2007-05-09 PTC Therapeutics, Inc. Thienopyridines for treating hepatitis c
EP1962892A4 (en) * 2005-11-22 2011-10-12 Univ South Florida INHIBITION OF CELL PROLIFERATION
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
AU2007254165A1 (en) * 2006-05-17 2007-11-29 Forschungsverbund Berlin E.V. Pyrimidine low molecular weight ligands for modulating hormone receptors
CA2653654A1 (en) 2006-06-06 2007-12-21 Boehringer Ingelheim International Gmbh Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use
RU2444524C2 (ru) * 2006-08-21 2012-03-10 Дженентек, Инк. Азабензотиофенильные соединения и способы применения
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
ES2365966T3 (es) 2007-09-14 2011-10-14 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 4-(aril-x-fenil)-1h-piridin-2-onas 1,3-disustituidas.
TWI445532B (zh) 2007-09-14 2014-07-21 Janssen Pharmaceuticals Inc １’，３’－二取代－４－苯基－３，４，５，６－四氫－２ｈ，１’ｈ－〔１，４’〕聯吡啶基－２’－酮化物
ES2409215T3 (es) * 2007-09-14 2013-06-25 Janssen Pharmaceuticals, Inc. 4-fenil-1H-piridin-2-onas 1-3-disustituidas
US8653282B2 (en) * 2007-10-18 2014-02-18 Boehringer Ingelheim International Gmbh Preparation of dihydrothieno [3,2-D] pyrimidines and intermediates used therein
CA2704436C (en) 2007-11-14 2016-01-05 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
US8691849B2 (en) 2008-09-02 2014-04-08 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
CN102186477B (zh) 2008-10-16 2013-07-17 奥梅-杨森制药有限公司 作为代谢型谷氨酸受体调节剂的吲哚和苯并吗啉衍生物
CN102232074B (zh) 2008-11-28 2014-12-03 奥梅-杨森制药有限公司 作为代谢性谷氨酸盐受体调节剂的吲哚和苯并噁嗪衍生物
EP2430022B1 (en) 2009-05-12 2013-11-20 Janssen Pharmaceuticals, Inc. 1,2,4-Triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
ES2409006T3 (es) 2009-05-12 2013-06-24 Janssen Pharmaceuticals Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de los receptores mGluR2
AU2011328194B2 (en) 2010-11-08 2015-04-16 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JP5852665B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
WO2012062759A1 (en) 2010-11-08 2012-05-18 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
AU2012286048A1 (en) 2011-07-18 2014-02-20 Arts Biologics A/S Long acting luteinizing hormone (LH) compound
EP2782917B1 (en) 2011-11-23 2016-03-02 Cancer Research Technology Limited Thienopyrimidine inhibitors of atypical protein kinase c
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
LT3096790T (lt) 2014-01-21 2019-10-10 Janssen Pharmaceutica, N.V. Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas
UA127921C2 (uk) 2014-01-21 2024-02-14 Янссен Фармацевтика Нв Комбінації, які містять позитивні алостеричні модулятори або ортостеричні агоністи метаботропного глутаматергічного рецептора 2 підтипу, та їх застосування
CN107602585A (zh) * 2017-10-23 2018-01-19 遵义医学院 噻吩并吡啶双杂环化合物的制备工艺
BR102019022529A2 (pt) * 2019-10-25 2021-05-04 Anhanguera Educacional Ltda. Processo para obtenção de composições farmacêuticas antitumorais através de butadienos push-pull, compostos e seus usos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3262593A (en) * 1992-01-11 1993-08-03 Schering Agrochemicals Limited Biheterocyclic fungicidal compounds
TW449600B (en) * 1994-04-19 2001-08-11 Takeda Chemical Industries Ltd Condensed-ring thiophene derivatives, their production and use
JP3854648B2 (ja) * 1994-04-19 2006-12-06 武田薬品工業株式会社 縮合チオフェン誘導体、その製造法及び用途
ATE225351T1 (de) 1994-11-08 2002-10-15 Takeda Chemical Industries Ltd Thienopyridin und thienopyrimidinderivate und ihre verwendung als entzündungshemmende mittel
JPH09169767A (ja) * 1995-10-19 1997-06-30 Takeda Chem Ind Ltd 複素環化合物、その製造法および用途
EP0862573A1 (en) * 1995-10-19 1998-09-09 Takeda Chemical Industries, Ltd. Thienopyridine derivatives as gonadotropin releasing hormone antagonists
JPH09169766A (ja) * 1995-10-19 1997-06-30 Takeda Chem Ind Ltd チエノピリジン誘導体，その製造法および用途
ID17260A (id) * 1996-04-26 1997-12-11 Takeda Chemical Industries Ltd Turunan tieno piridina dan produksi serta gunanya

Also Published As

Publication number Publication date
HK1041266A1 (en) 2002-07-05
AR028474A1 (es) 2003-05-14
EP1171443A1 (en) 2002-01-16
ID30502A (id) 2001-12-13
AU3816600A (en) 2000-11-14
ATE299507T1 (de) 2005-07-15
CA2368834C (en) 2009-11-03
CZ20013605A3 (cs) 2002-03-13
CN1177848C (zh) 2004-12-01
TR200102839T2 (tr) 2002-04-22
NO20014824L (no) 2001-10-04
PL219316B1 (pl) 2015-04-30
NZ514445A (en) 2003-07-25
US6841553B2 (en) 2005-01-11
DE60021262T2 (de) 2006-01-05
PE20010030A1 (es) 2001-01-27
HU229002B1 (en) 2013-07-29
HUP0200653A3 (en) 2004-07-28
HK1041266B (en) 2005-09-16
US6569863B1 (en) 2003-05-27
MXPA01010144A (es) 2002-04-24
WO2000061586A1 (en) 2000-10-19
IL145483A (en) 2007-06-03
CZ300832B6 (cs) 2009-08-19
CO5160348A1 (es) 2002-05-30
EP1171443B1 (en) 2005-07-13
JP2002541259A (ja) 2002-12-03
DK1171443T3 (da) 2005-11-07
NO20014824D0 (no) 2001-10-04
BR0009558A (pt) 2002-02-19
JP4854856B2 (ja) 2012-01-18
KR20010103801A (ko) 2001-11-23
RU2248979C2 (ru) 2005-03-27
PL350964A1 (en) 2003-02-24
ES2245304T3 (es) 2006-01-01
CN1349535A (zh) 2002-05-15
AU772258B2 (en) 2004-04-22
ZA200107917B (en) 2003-09-23
HUP0200653A2 (en) 2002-06-29
US20030212081A1 (en) 2003-11-13
BRPI0009558B1 (pt) 2016-10-25
DE60021262D1 (de) 2005-08-18
CA2368834A1 (en) 2000-10-19
PT1171443E (pt) 2005-11-30
KR100691546B1 (ko) 2007-03-12
TW564247B (en) 2003-12-01
NO328826B1 (no) 2010-05-25

Similar Documents

Publication Publication Date Title
IL145483A0 (en) Bicyclic heteroaromatic compounds useful as lh agonists
HUP0203375A3 (en) Substituted oxoazaheterocyclyl compounds
IL141029A0 (en) 2-substituted-1- piperidyl benzimidazole compounds as orl1-receptor agonists
EP1206262A4 (en) Y NEUROPEPTID ANTAGONISTS: SPIROISOQUINOLINONE DERIVATIVES
GB9929973D0 (en) Heterocyclic compounds
IL146210A0 (en) Pyrimidinone compounds
IL148997A0 (en) Bicyclic imidazo-3-yl-amine derivatives
IL150059A0 (en) Novel heterocycles
EP1155698A4 (en) ORGANOBORAL COMPOUNDS HAVING COCCIDIOSTAT ACTIVITY
NZ513732A (en) Heterocyclic benzenesulphonamide compounds as bradykinine antagonists
PL355098A1 (en) Imidazole compounds used as phosphodiesterase vii inhibitors
EG25796A (en) Indanamide derivatives as muscarinic agonists
IL148623A0 (en) Thienoisoxazolyl-and thienylpyrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists
IL154624A (en) Bicyclic heteroaromatic compounds
HUP0200830A3 (en) Process for the preparation of substituted pyrimidines
SI1261588T1 (en) IMIDAZOLE COMPOUNDS AS Alpha2-ADRENOCEPTORS ANTAGONISTS
EP1202738A4 (en) DIHYDROPYRAZINE DERIVATIVES AS NPY ANTAGONISTS
AUPQ346999A0 (en) Substituted diboron compounds
GB9915180D0 (en) Antitumour compound
ZA200108302B (en) Substituted bicyclic heteroaryl compounds as integrin antagonists.
SI1155013T1 (en) Heterocyclic benzenesulphonamide compounds as bradykinine antagonists
SI1200414T1 (en) Process for the preparation of substituted pyrimidines
HK1048123A (en) Substituted diboron compounds
GB9916218D0 (en) Heterocyclic compounds
GB9916216D0 (en) Heterocyclic compounds

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed